Differential genomic DNA methylation has the potential to influence the development of T cell cytokine production profiles. Therefore, we have conducted a clonal analysis of interferon (IFN)-γ and interleukin (IL)-3 gene methylation and messenger (m)RNA expression in primary CD8+ T cells during the early stages of activation, growth, and cytokine expression. Despite similar distributions and densities of CpG methylation sites, the IFN-γ and IL-3 promoters exhibited differential demethylation in the same T cell clone, and heterogeneity between clones. Methylation patterns and mRNA levels were correlated for both genes, but demethylation of the IFN-γ promoter was widespread across >300 basepairs in clones expressing high levels of IFN-γ mRNA, whereas demethylation of the IL-3 promoter was confined to specific CpG sites in the same clones. Conversely, the majority of clones expressing low or undetectable levels of IFN-γ mRNA exhibited symmetrical methylation of four to six of the IFN-γ promoter CpG sites. Genomic DNA methylation also has the potential to influence the maintenance or stability of T cell cytokine production profiles. Therefore, we also tested the heritability of IFN-γ gene methylation and mRNA expression in families of clones derived from resting CD44lowCD8+ T cells or from previously activated CD44highCD8+ T cells. The patterns of IFN-γ gene demethylation and mRNA expression were faithfully inherited in all clones derived from CD44high cells, but variable in clones derived from CD44low cells. Overall, these findings suggest that differential genomic DNA methylation, including differences among cytokine genes, among individual T cells, and among T cells with different activation histories, is an important feature of cytokine gene expression in primary T cells.
Skip Nav Destination
Article navigation
1 July 1998
Article|
July 01 1998
Distinct Methylation of the Interferon γ (IFN-γ) and Interleukin 3 (IL-3) Genes in Newly Activated Primary CD8+ T Lymphocytes: Regional IFN-γ Promoter Demethylation and mRNA Expression Are Heritable in CD44highCD8+ T Cells
David R. Fitzpatrick,
David R. Fitzpatrick
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
Kym M. Shirley,
Kym M. Shirley
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
Louise E. McDonald,
Louise E. McDonald
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
Helle Bielefeldt-Ohmann,
Helle Bielefeldt-Ohmann
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
Graham F. Kay,
Graham F. Kay
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
Anne Kelso
Anne Kelso
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Search for other works by this author on:
David R. Fitzpatrick
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Kym M. Shirley
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Louise E. McDonald
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Helle Bielefeldt-Ohmann
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Graham F. Kay
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Anne Kelso
From the *Leukocyte Biology Unit and the ‡Cancer Research Unit, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, Queensland 4029, Australia; and the §Department of Microbiology, University of Queensland, St. Lucia, Queensland 4072, Australia
Address correspondence to David R. Fitzpatrick, Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, QLD 4029, Australia. Phone: 61-7-3362-0379/0380; Fax: 61-7-3362-0105; E-mail: [email protected]
Received:
September 22 1997
Revision Received:
March 23 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1998
J Exp Med (1998) 188 (1): 103–117.
Article history
Received:
September 22 1997
Revision Received:
March 23 1998
Citation
David R. Fitzpatrick, Kym M. Shirley, Louise E. McDonald, Helle Bielefeldt-Ohmann, Graham F. Kay, Anne Kelso; Distinct Methylation of the Interferon γ (IFN-γ) and Interleukin 3 (IL-3) Genes in Newly Activated Primary CD8+ T Lymphocytes: Regional IFN-γ Promoter Demethylation and mRNA Expression Are Heritable in CD44highCD8+ T Cells . J Exp Med 1 July 1998; 188 (1): 103–117. doi: https://doi.org/10.1084/jem.188.1.103
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement